Mr. Kristin Viccars reports

AURORA IMPROVES OFFERINGS IN AUSTRALIA WITH NEW RANGE OF PREMIUM DRIED FLOWER PRODUCTS

Aurora Cannabis Inc., in conjunction with MedReleaf Australia, has expanded its portfolio with the introduction of a new range of premium dried cannabis flower products. Now available for doctors to prescribe to patients in Australia, the new products, developed by Aurora and manufactured at its EU-GMP (European Union good agricultural practice) and TGA-GMP (Therapeutic Goods Administration good agricultural practice) certified facility, will be distributed by MedReleaf Australia, a premier distributor of medical cannabis products holding the second position in the Australian market.

The new dried flowers, including Black Jelly, Chemango Kush and Moon Berry, are proprietary cultivars cultivated exclusively by Aurora. Vespera, a previously existing proprietary cultivar, is also set for relaunch under the Aurora brand. These products mark a significant step forward for MedReleaf Australia as it continues to expand its offerings under the Aurora brand. The dried flower products are available now in four 10-gram formats including:

• Aurora Moon Berry T9/C13 balanced;
• Aurora Black Jelly T28/C1 sativa;
• Aurora Chemango Kush T29/C1 indica;
• Aurora Vespera T1/C17 cannabidiol.

"This expanded offering aims to serve patients with more choice, novel cultivars and expertly grown product," said Kristin Viccars, managing director at MedReleaf Australia. "With the launch of the new Aurora dried flower products, MedReleaf Australia reaffirms its commitment to providing high-quality medical cannabis solutions that meet the diverse needs of patients across Australia."

The expanded range of Aurora products caters to the market demand for more affordable options without compromising on quality. With a focus on sustainability, the 2.0 genetics employed in these cultivars ensure reliable large-scale cultivation to meet market demand while maintaining elevated quality standards.

Furthermore, the MedReleaf Australia family of brands now focuses on three core brands -- CraftPlant, offering a hand-crafted, premium range of products; Aurora, for innovative and affordable options; and IndiMed, providing a company-financed concession range.

About Aurora Cannabis Inc.

Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and South America. Headquartered in Edmonton, Alta., Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands Pedanios, Bidiol, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched.

We seek Safe Harbor.